Ligand validation:5ZHX

FAR: FARNESYL

FAR is a Ligand Of Interest in 5ZHX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ZHX_FAR_h_201	42%	17%	0.201	0.923	2.51	1.17	2	1	0	0	100%	1
5ZHX_FAR_f_201	42%	15%	0.229	0.949	2.6	1.25	2	1	0	0	100%	1
5ZHX_FAR_g_201	17%	17%	0.271	0.853	2.62	1.04	2	1	0	0	100%	1
5ZHX_FAR_e_201	14%	16%	0.289	0.839	2.55	1.16	2	2	0	0	100%	1
5FR2_FAR_A_1190	13%	1%	0.382	0.926	3.57	4.6	4	11	1	0	100%	1
5TB5_FAR_A_201	63%	40%	0.148	0.944	0.66	1.65	-	5	0	0	100%	1
2H6H_FAR_P_2010	59%	70%	0.161	0.945	0.6	0.54	-	-	0	0	100%	1
7Q9U_FAR_BBB_203	58%	75%	0.17	0.951	0.29	0.67	-	-	3	0	100%	1
7Q9S_FAR_AAA_202	57%	74%	0.124	0.9	0.27	0.74	-	-	0	0	100%	1
1KZP_FAR_C_12	50%	71%	0.189	0.94	0.39	0.72	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.